Status:
COMPLETED
A Study to Evaluate Solifenacin Succinate in Combination With Tamsulosin for the Treatment of Residual Overactive Bladder Symptoms (OAB) in Men.
Lead Sponsor:
Astellas Pharma Inc
Conditions:
Urinary Incontinence
Eligibility:
MALE
45+ years
Phase:
PHASE4
Brief Summary
A study to evaluate solifenacin succinate in combination with tamsulosin for the treatment of residual OAB symptoms in men.
Detailed Description
A 2 arm study ( 1 Active, 1 Placebo) to evaluate solifenacin succinate in combination with tamsulosin for the treatment of residual OAB symptoms in men
Eligibility Criteria
Inclusion
- Symptoms of Overactive Bladder (OAB)
Exclusion
- Current use of antimuscarinic therapy
- Evidence of a urinary tract infection
Key Trial Info
Start Date :
May 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2007
Estimated Enrollment :
398 Patients enrolled
Trial Details
Trial ID
NCT00333112
Start Date
May 1 2006
End Date
January 1 2007
Last Update
September 18 2014
Active Locations (74)
Enter a location and click search to find clinical trials sorted by distance.
1
Birmingham, Alabama, United States, 35209
2
Phoenix, Arizona, United States, 85050
3
Tuscon, Arizona, United States, 85712
4
Atherton, California, United States, 94027